12:51 PM
 | 
Jun 09, 2017
 |  BC Week In Review  |  Clinical News  |  Regulatory

EMA accepts MAA for Humira biosimilar from Fujifilm, Kyowa

Fujifilm Kyowa Kirin Biologics Co. Ltd., a JV between Fujifilm Holdings Corp. (Tokyo:4901) and Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), said EMA accepted...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >